M.A. Karsdal

2000–2025 年に発表

328
論文数
25,650
被引用数
93
h 指数
305
i10 指数

被引用数

M.A. Karsdal の年別被引用数1982 年: 被引用 1 件1984 年: 被引用 1 件2000 年: 被引用 1 件2001 年: 被引用 1 件2002 年: 被引用 4 件2003 年: 被引用 16 件2004 年: 被引用 34 件2005 年: 被引用 47 件2006 年: 被引用 70 件2007 年: 被引用 60 件2008 年: 被引用 84 件2009 年: 被引用 116 件2010 年: 被引用 112 件2011 年: 被引用 156 件2012 年: 被引用 152 件2013 年: 被引用 178 件2014 年: 被引用 172 件2015 年: 被引用 201 件2016 年: 被引用 213 件2017 年: 被引用 227 件2018 年: 被引用 249 件2019 年: 被引用 803 件2020 年: 被引用 1,149 件2021 年: 被引用 1,407 件2022 年: 被引用 1,133 件2023 年: 被引用 895 件2024 年: 被引用 1,592 件2025 年: 被引用 934 件2026 年: 被引用 36 件1983 年は被引用が無いため表示していません1985〜1999 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,055 件、この内訳の 18.5%中国: 引用元論文 1,518 件、この内訳の 13.6%イギリス: 引用元論文 865 件、この内訳の 7.8%ドイツ: 引用元論文 630 件、この内訳の 5.7%デンマーク: 引用元論文 570 件、この内訳の 5.1%イタリア: 引用元論文 460 件、この内訳の 4.1%オーストラリア: 引用元論文 373 件、この内訳の 3.4%フランス: 引用元論文 370 件、この内訳の 3.3%オランダ: 引用元論文 350 件、この内訳の 3.1%スペイン: 引用元論文 339 件、この内訳の 3%カナダ: 引用元論文 311 件、この内訳の 2.8%日本: 引用元論文 240 件、この内訳の 2.2%
0%18.5%その他 27.4%

分野

  • Medicine65.8%
  • Biochemistry, Genetics and Molecular Biology22.6%
  • Immunology and Microbiology2.7%
  • Engineering1.9%
  • Neuroscience1.5%
  • Materials Science1.2%
  • その他4.3%

トピック

  • Osteoarthritis Treatment and Mechanisms6.7%
  • Liver Disease Diagnosis and Treatment4.7%
  • Bone Metabolism and Diseases3%
  • Rheumatoid Arthritis Research and Therapies2%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis1.7%
  • Bone health and treatments1.7%
  • その他80.2%

共著者

全論文

検索で開く
  1. Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guruprasad P. Aithal, Jörn M. Schattenberg, Elisabetta Bugianesi, Manuel Romero‐Gómez, Vlad Ratziu, Quentin M. Anstee, Patrick M. Bossuyt - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 196

  2. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Vlad Ratziu, Karine Clément, Raluca Pais, Detlef Schuppan, Jörn M. Schattenberg, Toni Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas, Evangelia Petsalaki, Matej Orešič, Tuulia Hyötyläinen, Aiden McGlinchey, José M. Mato, Óscar Millet, Jean‐François Dufour, Annalisa Berzigotti, Michael Pavlides, Stephen A. Harrison, Stefan Neubauer, Jeremy Cobbold, Ferenc E. Mózes, Salma Akhtar, Rajarshi Banerjee, Matt Kelly, Elizabeth Shumbayawonda, Andrea Dennis, Charlotte Erpicum, Manuel Romero‐Gómez, Emilio Gómez-González, Javier Ampuero, Javier Castell, Rocío Gallego‐Durán, Isabel Fernández-Lizaranzu, Rocío Montero‐Vallejo, M.A. Karsdal, Elisabeth Erhardtsen, Daniel Guldager Kring Rasmussen, Diana Julie Leeming, Mette Juul Fisker, Antonia Sinisi, Kishwar Musa, Fay Betsou, Estelle Sandt, Manuela Tonini, Elisabetta Bugianesi, Chiara Rosso, Angelo Armandi, Fabio Marra, Amalia Gastaldelli, Gianluca Svegliati, Jérôme Boursier, Sven Francque, Luisa Vonghia, Mattias Ekstedt, Stergios Kechagias, Hannele Yki‐Järvinen, Panu K. Luukkonen, Saskia W. C. van Mil, George Papatheodoridis, Helena Cortez‐Pinto, Luca Valenti, Salvatore Petta, Luca Miele, Andreas Geier ほか 35 名 - Journal of Hepatology 2021 被引用: 353

  3. The good and the bad collagens of fibrosis – Their role in signaling and organ function

    著者: , , , , , , , , , , , , - Advanced Drug Delivery Reviews 2017 被引用: 502

  4. Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology

    著者: , , - Journal of Experimental & Clinical Cancer Research 2019 被引用: 495

  5. Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use

    著者: , , , , - Osteoarthritis and Cartilage 2015 被引用: 653

  6. Recent advances in understanding the phenotypes of osteoarthritis

    著者: , , , , , - F1000Research 2019 被引用: 214

  7. Disease-modifying treatments for osteoarthritis (DMOADs) of the knee and hip: lessons learned from failures and opportunities for the future

    著者: , , , , , , , , , - Osteoarthritis and Cartilage 2016 被引用: 384

  8. BMS‐986263 in patients with advanced hepatic fibrosis: 36‐week results from a randomized, placebo‐controlled phase 2 trial

    著者: , , , , , , , , , , , - Hepatology 2021 被引用: 100

  9. Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2021 被引用: 141

  10. Collagen‐mediated hemostasis

    著者: , , - Journal of Thrombosis and Haemostasis 2016 被引用: 228

  11. The minor collagens in articular cartilage

    著者: , , , , , , , - Protein & Cell 2017 被引用: 261

  12. ADAPT: An Algorithm Incorporating PRO‐C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis

    著者: , , , , , , , , , , , , , , , , , - Hepatology 2018 被引用: 257

  13. Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix

    著者: , , , , - Frontiers in Immunology 2023 被引用: 65

  14. The collagen landscape in cancer: profiling collagens in tumors and in circulation reveals novel markers of cancer‐associated fibroblast subtypes

    著者: , , , , , , - The Journal of Pathology 2023 被引用: 92

  15. Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peer Bork, Mathias Mann, Jelle Matthijnssens, Aleksander Krag, Torben Hansen - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 75

  16. Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial

    著者: , , , , , , , , , , , , , , , , , - Journal of Hepatology 2018 被引用: 180

  17. Dermal fibroblasts have different extracellular matrix profiles induced by TGF-β, PDGF and IL-6 in a model for skin fibrosis

    著者: , , , , , , - Scientific Reports 2020 被引用: 125

  18. Novel insights into the function and dynamics of extracellular matrix in liver fibrosis

    著者: , , , , , , , , , , , , , - American Journal of Physiology-Gastrointestinal and Liver Physiology 2015 被引用: 269

  19. Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease

    著者: , , , , , , , , , , , , , , , - JHEP Reports 2019 被引用: 132

  20. Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction

    著者: , , , , , , , , , , , , , , , , , , - eLife 2021 被引用: 84

  21. Value of biomarkers in osteoarthritis: current status and perspectives

    著者: , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2013 被引用: 325

  22. Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study

    著者: , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2015 被引用: 324

  23. Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort

    著者: , , , , , , , , , , , , , , , , - Respiratory Research 2019 被引用: 142

  24. Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Torben Hansen, Matthias Mann, Jelle Matthijnssens, Aleksander Krag, Aleksander Krag, Peer Bork, Torben Hansen, Manimozhiyan Arumugam, Jonel Trebicka, M.A. Karsdal, Ema Anastasiadou, Hans Israelsen, Hans Olav Melberg, Cristina Legido‐Quigley, Maja Thiele - Journal of Hepatology 2024 被引用: 57